Showing all results Page 4 of 17

Healthcare outlook 2024

November 1st, 2023

A recovery in the global economy will cause a return to spending growth in the healthcare sector. However, it will remain vulnerable to headwinds, including limited resources, stricter regulations and continued strikes.

  • Campaign
  • Cardiovascular surgery
  • Centralised Diagnostics (CEDx)
  • Covid-19 testing
  • General surgery
  • In-vitro diagnostics
  • Infectious Diseases Testing Monitor
  • Next Generation Sequencing (NGS)
  • Surgical device
  • Global

Point-of-care testing: promises and challenges

October 13th, 2023

Point-of-care testing (POCT) has long been touted as a revolutionary technology that has the potential to transform healthcare. By providing fast, convenient, and affordable testing options, POCT can help to improve patient care and reduce costs

  • Clearstate Insights
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Uncategorised

Spine trends in orthopaedics

September 28th, 2023

The Southeast Asia (SEA) market witnessed significant double-digit growth in spinal procedure volumes from 2021-22, due to the lifting of covid-19 restrictions and fewer backlog surgeries.

Clearstate’s report highlights the competitive landscape and trends shaping the region’s orthopaedic spinal market.

  • Campaign
  • Orthopaedic & Spine Surgery
  • Asia

Trends shaping the IVD demand in emerging markets

September 27th, 2023

Clearstate’s latest infographic looks at the micro and macro economic trends influencing the future of IVD demand in emerging markets in APAC and LATAM.

  • Campaign
  • In-vitro diagnostics
  • Global

Orthopaedics: trauma trends in SEA – Thank you

August 15th, 2023

Lifted restrictions post-covid-19 increased traffic accidents in SEA markets (particularly in Malaysia, Indonesia and Thailand) and led to an increase in fracture volumes, with double-digit growth observed from 2021 to 2022.

  • Campaign
  • Orthopaedic & Spine Surgery
  • Surgical device
  • Asia

Orthopaedics: trauma trends in SEA

August 15th, 2023

Lifted restrictions post-covid-19 increased traffic accidents in SEA markets (particularly in Malaysia, Indonesia and Thailand) and led to an increase in fracture volumes, with double-digit growth observed from 2021 to 2022.

  • Campaign
  • Orthopaedic & Spine Surgery
  • Surgical device
  • Asia

Inside APAC’s IVD market

July 31st, 2023

Over the past two years, the global in-vitro diagnostics (IVD) sector has experienced various shifts and developments. The pandemic’s far-reaching impact across economies and healthcare systems has affected everything from IVD testing trends, to laboratory capacities. As covid-19 becomes endemic, IVD companies are reassessing their priorities based on future growth opportunities and challenges.

  • Campaign
  • Uncategorised
  • Asia

Orthopaedics: joint replacement trends in SEA – Thank you

July 21st, 2023

As the covid-19 pandemic transitioned into an endemic phase, individuals resumed seeking medical treatment, leading to an increase in elective procedures. In Southeast Asia* (SEA), there was a significant growth in joint replacement procedure volumes, with double-digit growth observed from 2021 to 2022.

  • Campaign

Orthopaedics: joint replacement trends in SEA

July 21st, 2023

As the covid-19 pandemic transitioned into an endemic phase, individuals resumed seeking medical treatment, leading to an increase in elective procedures. In Southeast Asia* (SEA), there was a significant growth in joint replacement procedure volumes, with double-digit growth observed from 2021 to 2022.

  • Campaign
  • Orthopaedic & Spine Surgery
  • Surgical device
  • Global

Segment Trend Report

Understand the high-level segment value and trends driving market demand of main IVD segments, then these Segment Trend reports would meet your needs.

  • Solutions

Growth opportunities for IVD companies in APAC and LATAM

June 19th, 2023

Growth opportunities from covid-19 have helped fuel rapid expansion for both established and emerging IVD companies. IVD companies have tapped into the increased global demand to drive growth, with some companies doubling their revenues during the pandemic years. 

  • Campaign
  • Centralised Diagnostics (CEDx)
  • In-vitro diagnostics
  • Point-of-care testing (POCT)
  • Tissue Diagnostics (TDx)
  • Americas
  • Asia